All Journal Guides

Journal Guide

Diabetes Care Impact Factor 16.6: Publishing Guide

Diabetes management: clinical outcomes, prevention, and treatment

16.6

Impact Factor (2024)

~30-40%

Acceptance Rate

~100-130 days median

Time to First Decision

What Diabetes Care Publishes

Diabetes Care published by the American Diabetes Association is the premier journal for clinical diabetes research. With JIF 16.6 and Q1 ranking in Endocrinology & Metabolism, DC emphasizes rigorous diabetes clinical research. The journal publishes research on diabetes treatment, prevention, and patient outcomes. Critically: DC values research with clear clinical diabetes significance and patient outcomes. Basic metabolism research without diabetes relevance is less competitive. The journal seeks papers advancing diabetes care and patient health.

  • Type 1 diabetes: insulin therapy, islet transplant, autoimmunity, prevention
  • Type 2 diabetes: treatment, prevention, lifestyle, medication efficacy
  • Gestational diabetes: pregnancy outcomes, prevention, maternal health
  • Complications: nephropathy, retinopathy, neuropathy, cardiovascular disease
  • Glycemic control: monitoring, insulin delivery, glucose management
  • Diabetes prevention: lifestyle interventions, primary prevention, weight management
  • Medication development: new agents, combination therapy, real-world outcomes
  • Diabetes epidemiology: risk factors, disparities, population health

Editor Insight

Diabetes Care publishes clinical diabetes advancing treatment and prevention. We seek rigorous studies with adequate follow-up and attention to patient outcomes across populations.

What Diabetes Care Editors Look For

Diabetes treatment or prevention advancing patient outcomes

Present research improving diabetes management. Better glucose control? Fewer complications? Prevention success? Show patient benefit.

Clinical trial or large cohort with rigorous outcome assessment

Adequate patient numbers and follow-up. Randomized trials or large observational studies with clinical endpoints.

Mechanistic understanding of diabetes pathology or treatment response

Explain why therapy works. What mechanisms drive glucose control? Why do complications occur?

Real-world applicability and practical implementation

Show findings work in clinical practice. Address barriers to implementation, cost-effectiveness.

Attention to diabetes disparities and diverse populations

Consider outcomes across racial, ethnic, socioeconomic groups. Address healthcare equity.

Why Papers Get Rejected

These patterns appear repeatedly in manuscripts that don't make it past Diabetes Care's editorial review:

Basic metabolism or biochemistry without diabetes clinical context

DC expects clinical diabetes relevance. Metabolic studies alone insufficient. How do findings help diabetes patients?

Small sample sizes or inadequate follow-up for clinical significance

Clinical diabetes research requires adequate power. Short follow-up unconvincing for chronic disease.

No discussion of clinical implications or implementation challenges

Connect to diabetes practice. How would this change patient care?

Ignoring disparities and populations affected

Diabetes affects diverse populations. Address whether findings apply broadly.

Cost analysis missing for treatment studies

Diabetes treatment decisions include cost. Address cost-effectiveness.

Does your manuscript avoid these patterns?

The quick diagnostic reads your full manuscript against Diabetes Care's criteria and flags the specific issues most likely to cause rejection.

Run Free Readiness Scan →

Insider Tips from Diabetes Care Authors

Type 2 diabetes prevention and lifestyle intervention outcomes valued

Prevention strategies and practical lifestyle implementation highly competitive.

Novel medications and real-world outcomes increasingly important

New medication classes (GLP-1, SGLT2i) and their clinical effectiveness in diverse populations trending.

Glycemic variability and continuous glucose monitoring research competitive

Emerging technologies enabling better glucose monitoring increasingly studied.

Diabetes-related complications and prevention increasingly emphasized

Research preventing nephropathy, retinopathy, neuropathy increasingly important.

Health equity and disparities increasingly highlighted

Addressing diabetes disparities across populations increasingly important.

The Diabetes Care Submission Process

1

Manuscript preparation

Prep

5,000-8,000 words with 5-7 figures. Include diabetes patient cohort, treatment/prevention description, outcome measures, follow-up data, mechanistic discussion, disparities consideration.

2

Submission via ADA system

Day 0

Submit at https://diabetescare.diabetesjournals.org/. Required: manuscript emphasizing clinical significance, figures showing outcomes, cover letter highlighting patient impact.

3

Editorial assessment

1-2 weeks

Editor assesses clinical diabetes novelty. Papers lacking adequate sample size or outcomes face lower priority. Moderate desk rejection ~30-40%.

4

Peer review

100-130 days

2-3 diabetes experts assess study design, outcome rigor, clinical significance, and disparities awareness. First decision 100-130 days.

5

Revision and publication

Revision: 4-8 weeks

Revisions often request additional outcome data or disparities analysis. Publication 2-4 weeks after acceptance.

Diabetes Care by the Numbers

2024 Impact Factor5.3
5-Year Impact Factor5.6
Acceptance rate~30-40%
Desk rejection rate~30-40%
Median first decision~115 days
Open access option$3,400 USD
PublisherAmerican Diabetes Association
Founded1978

Before you submit

Diabetes Care accepts a small fraction of submissions. Make your attempt count.

The pre-submission diagnostic runs a live literature search, scores your manuscript section by section, and gives you a prioritized fix list calibrated to Diabetes Care. ~30 minutes.

Article Types

Clinical Research

5,000-8,000 words

Diabetes treatment or prevention with outcomes

Original Article

5,000-8,000 words

Diabetes-related clinical research

Landmark Diabetes Care Papers

Papers that defined fields and changed science:

  • Diabetes prevention trials (1990s+) - preventing type 2 diabetes
  • Intensive glycemic control outcomes (2000s+) - DCCT paradigm
  • GLP-1 and cardiovascular outcomes (2010s+) - new medication benefits
  • Complications prevention (various) - nephropathy and retinopathy

Preparing a Diabetes Care Submission?

Get pre-submission feedback from reviewers who've published in Diabetes Care and know exactly what editors look for.

Run Free Readiness Scan

Need expert depth? Human review from $1,000

NDA-protected
Confidential

Primary Fields

Type 2 DiabetesDiabetes PreventionComplicationsMedicationGlycemic Control